Doxorubicin Liposomal
Janessa Smith, Pharm.D., BCPS
,
Paul A. Pham, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Treatment of AIDS-related
Kaposi’s sarcoma (KS)
Ovarian cancer
Multiple myeloma
Ovarian cancer (advanced)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Breast cancer (metastatic)
Cutaneous T-cell lymphomas
Hodgkin’s lymphoma (salvage treatment)
Soft tissue sarcoma (advanced)
Uterine sarcoma (advanced or recurrent)
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.